Realtrex Nasal Spray 240 Sprays

Product Description:

• RYALTRIS is a combination of olopatadine, a histamine-1 (H1) receptor antagonist, and mometasone furoate, a corticosteroid, indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.

Directions for use:

• Take RYALTRIS® by nasal route only.
• Patients should be instructed to shake the bottle well before each use and to use RYALTRIS® before initial use.
• Prime by pressing the pump quickly and firmly 6 times, then release the spray into the air away from the eyes and face until a fine mist appears.
• If you have not used RYALTRIS® for 14 days or more, you will need to shake the bottle well and prime the pump with two sprays or until a fine mist appears.
• Avoid spraying RYALTRIS® into the eyes or mouth.

Warnings and Precautions:

• Epistaxis, nasal ulcers, nasal septal perforations, impaired wound healing, Candida albicans infection: Monitor patients periodically for signs of adverse reactions to the nasal mucosa.
• Drowsiness: Avoid hazardous activities that require full mental alertness and motor coordination, such as driving or operating machinery, when taking Rialtrex.
• Avoid concomitant use of alcohol or other CNS depressants with RYALTRIS because further decreased alertness and impaired CNS performance may occur.
• Glaucoma and Cataracts: Monitor patients for changes in vision or who have a history of increased intraocular pressure, glaucoma and/or cataracts.
• Hypersensitivity reactions: Hypersensitivity reactions can occur with RYALTRIS. Hypersensitivity reactions including wheezing have occurred after intranasal administration of mometasone furoate. Discontinue use of RYALTRIS if such reactions occur.
• Immunosuppression and risk of infection: Possible exacerbation of existing tuberculosis. Fungal, bacterial, viral, or parasitic infections. Or ophthalmic herpes simplex. More severe or even fatal course of chickenpox or measles in susceptible patients: Use with caution in patients with the above due to the possibility of exacerbation of these infections.
• Hypercorticism and adrenal suppression may occur with misuse or use of doses higher than recommended or at the normal dose in patients at risk for such effects.

the components

• Mometasone furoate 25 micrograms and olopatadine 665 micrograms